Cargando…

Rapid identification of neutralizing antibodies against SARS-CoV-2 variants by mRNA display

The increasing prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants with the ability to escape existing humoral protection conferred by previous infection and/or immunization necessitates the discovery of broadly reactive neutralizing antibodies (nAbs). Utilizing mRNA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tanaka, Shiho, Olson, C. Anders, Barnes, Christopher O., Higashide, Wendy, Gonzalez, Marcos, Taft, Justin, Richardson, Ashley, Martin-Fernandez, Marta, Bogunovic, Dusan, Gnanapragasam, Priyanthi N.P., Bjorkman, Pamela J., Spilman, Patricia, Niazi, Kayvan, Rabizadeh, Shahrooz, Soon-Shiong, Patrick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Authors. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769934/ https://www.ncbi.nlm.nih.gov/pubmed/35114110 http://dx.doi.org/10.1016/j.celrep.2022.110348

Ejemplares similares

An ACE2 Triple Decoy that neutralizes SARS-CoV-2 shows enhanced affinity for virus variants
por: Tanaka, Shiho, et al.
Publicado: (2021)

Intranasal plus subcutaneous prime vaccination with a dual antigen COVID-19 vaccine elicits T-cell and antibody responses in mice
por: Rice, Adrian, et al.
Publicado: (2021)

Identification of an immune gene expression signature associated with favorable clinical features in Treg-enriched patient tumor samples
por: Givechian, Kevin B., et al.
Publicado: (2018)

Electron tomography visualization of HIV-1 fusion with target cells using fusion inhibitors to trap the pre-hairpin intermediate
por: Ladinsky, Mark S, et al.
Publicado: (2020)

CAD/POLD2 gene expression is associated with poor overall survival and chemoresistance in bladder urothelial carcinoma
por: Givechian, Kevin B., et al.
Publicado: (2018)

Glycolytic expression in lower-grade glioma reveals an epigenetic association between IDH mutation status and PDL1/2 expression
por: Givechian, Kevin B, et al.
Publicado: (2020)

Construction, characterization, and immunization of nanoparticles that display a diverse array of influenza HA trimers
por: Cohen, Alexander A., et al.
Publicado: (2021)

Learning subgroup-specific regulatory interactions and regulator independence with PARADIGM
por: Sedgewick, Andrew J., et al.
Publicado: (2013)

An immunogenic NSCLC microenvironment is associated with favorable survival in lung adenocarcinoma
por: Givechian, Kevin B., et al.
Publicado: (2019)

Comprehensive genomic transcriptomic tumor-normal gene panel analysis for enhanced precision in patients with lung cancer
por: Rabizadeh, Shahrooz, et al.
Publicado: (2018)

Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies
por: Jette, Claudia A., et al.
Publicado: (2021)

Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies
por: Jette, Claudia A., et al.
Publicado: (2021)

Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies
por: Jette, Claudia A., et al.
Publicado: (2021)

Deep Learning Implicitly Handles Tissue Specific Phenomena to Predict Tumor DNA Accessibility and Immune Activity
por: Wnuk, Kamil, et al.
Publicado: (2019)

Single-cell sequencing and tumorigenesis: improved understanding of tumor evolution and metastasis
por: Ellsworth, Darrell L., et al.
Publicado: (2017)

Dual-Antigen COVID-19 Vaccine Subcutaneous Prime Delivery With Oral Boosts Protects NHP Against SARS-CoV-2 Challenge
por: Gabitzsch, Elizabeth, et al.
Publicado: (2021)

Neutralizing monoclonal antibodies elicited by mosaic RBD nanoparticles bind conserved sarbecovirus epitopes
por: Fan, Chengcheng, et al.
Publicado: (2022)

Heterologous saRNA Prime, DNA Dual-Antigen Boost SARS-CoV-2 Vaccination Elicits Robust Cellular Immunogenicity and Cross-Variant Neutralizing Antibodies
por: Rice, Adrian, et al.
Publicado: (2022)

Identification and validation of expressed HLA-binding breast cancer neoepitopes for potential use in individualized cancer therapy
por: Reimann, Hannah, et al.
Publicado: (2021)

Peptidome Surveillance Across Evolving SARS-CoV-2 Lineages Reveals HLA Binding Conservation in Nucleocapsid Among Variants With Most Potential for T-Cell Epitope Loss in Spike
por: Wnuk, Kamil, et al.
Publicado: (2022)

A deep learning image-based intrinsic molecular subtype classifier of breast tumors reveals tumor heterogeneity that may affect survival
por: Jaber, Mustafa I., et al.
Publicado: (2020)

HIV-1 CD4-binding site germline antibody–Env structures inform vaccine design
por: Dam, Kim-Marie A., et al.
Publicado: (2022)

Vault Nanocapsules as Adjuvants Favor Cell-Mediated over Antibody-Mediated Immune Responses following Immunization of Mice
por: Kar, Upendra K., et al.
Publicado: (2012)

Immunotherapy utilizing the combination of natural killer– and antibody dependent cellular cytotoxicity (ADCC)–mediating agents with poly (ADP-ribose) polymerase (PARP) inhibition
por: Fenerty, Kathleen E., et al.
Publicado: (2018)

Correction to: Immunotherapy Utilizing the Combination of Natural Killer– and Antibody Dependent Cellular Cytotoxicity (ADCC)–Mediating Agents with Poly (ADP-ribose) polymerase (PARP) Inhibition
por: Fenerty, Kathleen E., et al.
Publicado: (2019)

Antibody elicited by HIV-1 immunogen vaccination in macaques displaces Env fusion peptide and destroys a neutralizing epitope
por: Abernathy, Morgan E., et al.
Publicado: (2021)

Toll-like Receptor-4 Activation Boosts the Immunosuppressive Properties of Tumor Cells-derived Exosomes
por: Domenis, Rossana, et al.
Publicado: (2019)

Stable transplantation of human mitochondrial DNA by high-throughput, pressurized isolated mitochondrial delivery
por: Sercel, Alexander J, et al.
Publicado: (2021)

Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice
por: Cohen, Alexander A., et al.
Publicado: (2021)

Overcoming hypoxia-induced functional suppression of NK cells
por: Solocinski, Kristen, et al.
Publicado: (2020)

PD-L1 targeting high-affinity NK (t-haNK) cells induce direct antitumor effects and target suppressive MDSC populations
por: Fabian, Kellsye P, et al.
Publicado: (2020)

ESCRT recruitment to SARS-CoV-2 spike induces virus-like particles that improve mRNA vaccines
por: Hoffmann, Magnus A.G., et al.
Publicado: (2023)

Nanoparticles presenting clusters of CD4 expose a universal vulnerability of HIV-1 by mimicking target cells
por: Hoffmann, Magnus A. G., et al.
Publicado: (2020)

Inferred Immune-Cell Activity Is an Independent Predictor of HER2-Negative Breast Cancer Prognosis and Response to Paclitaxel-Based Therapy in the GeparSepto Trial
por: Fasching, Peter A., et al.
Publicado: (2023)

Type I Interferons in Newborns—Neurotoxicity versus Antiviral Defense
por: Bogunovic, Dusan
Publicado: (2016)

Bourgeoning Scientific Research in Down Syndrome
por: Bogunovic, Dusan
Publicado: (2020)

Type I IFN is siloed in endosomes
por: Altman, Jennie B., et al.
Publicado: (2020)

The multi-functionality of N-809, a novel fusion protein encompassing anti-PD-L1 and the IL-15 superagonist fusion complex
por: Jochems, Caroline, et al.
Publicado: (2018)

Pro inflammatory stimuli enhance the immunosuppressive functions of adipose mesenchymal stem cells-derived exosomes
por: Domenis, Rossana, et al.
Publicado: (2018)

B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV
por: Scheid, Johannes F., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4pejuhoo5i1bb4ccbk9715erl4